Cutaneous small vessel vasculitis

References

• Carlson JA, Cavaliere LF, Grants-Kels JM. Cutaneous vasculitis: diagnosis and management. Clin Dermatol. 2006;24(5):414–429.
   PubMed Web of Science ®Google Scholar
• Calabrese LH, Michel BA, Bloch DA, et al. The American College of rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum. 1990;33(8):1108–1113.
   PubMed Web of Science ®Google Scholar
• Jennette JC, Falk RJ, Bacon PA, et al. Revised international chapel hill consensus conference nomenclature of vasculitidies. Arthritis Rheumatism. 2013;65(1):1–11. 2012.
   PubMed Web of Science ®Google Scholar
• Sunderkötter CH, Zelger B, Chen K-R, et al. Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 revised international chapel hill consensus Conference of Nomenclature of vasculitides. Arthritis Rheumatol Hoboken NJ. 2018;70(2):171–184.
   PubMed Web of Science ®Google Scholar
• Sanchez NP, Van Hale HM, Su WP. Clinical and histopathologic spectrum of necrotizing vasculitis: report of findings in 101 cases. Arch Dermatol. 1985;121(2):220–224.
   PubMedGoogle Scholar
• Shavit E, Alavi A, Sibbald RG. Vasculitis—What do we have to know? A review of literature. Int J Low Extrem Wounds. 2018;17(4):218–226.
   PubMed Web of Science ®Google Scholar
• Micheletti RG, Werth VP. Small vessel vasculitis of the skin. Rheum Dis Clin North Am. 2015;41(1):21–32.
   PubMed Web of Science ®Google Scholar
• Arora A, Wetter DA, Gonzalez-Santiago TM, et al. Incidence of leukocytoclastic vasculitis, 1996 to 2010: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc. 2014;89(11):1515–1524.
   PubMed Web of Science ®Google Scholar
• Fraticelli P, Benfaremo D, Gabrielli A. Diagnosis and management of leukocytoclastic vasculitis. Intern Emerg Med. 2021;16(4):831–841.
   PubMed Web of Science ®Google Scholar
• Eaf E, Callen JP. Cutaneous leukocytoclastic vasculitis. clinical and laboratory features of 82 patients seen in private practice. Arch Dermatol. 1984;120(4):484–489.
   PubMedGoogle Scholar
• Gonzalez-Gay MA, Lopez-Mejias R, Pina T, et al. IgA vasculitis: genetics and clinical and therapeutic management. Curr Rheumatol Rep. 2017;20(5):24.
   Web of Science ®Google Scholar
• Wetter DA, Dutz JP, Shinkai K, et al. Cutaneous vasculitis. In: Bolgonia JL, Schaffer JV, Cerroni L, editors. Dermatology. 2018;Vol. 4. 4th ed. China: Elsevier. p. 409–439.
   Google Scholar
• Ferri C, Mascia MT. Cryoglobulinemic vasculitis. Curr Opin Rheumatol. 2006;18(1):54–63.
   PubMed Web of Science ®Google Scholar
• Jachiet M, Flageul B, Deroux A, et al. The clinical spectrum and therapeutic management of hypo complement emic urticaria vasculitis colon data from a French nationwide study of 57 patients. Athritis Rheumatol. 2015;67(2):527–534.
   PubMed Web of Science ®Google Scholar
• Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol. 2008;9(2):71–92.
   PubMed Web of Science ®Google Scholar
• Carlson JA, Chen KR. Cutaneous vasculitis update: small vessel neutrophilic vasculitis syndromes. Am J dermatopathology. 2006;28(6):486–506.
   PubMed Web of Science ®Google Scholar
• Gardner-Medwin JM, Dolezalova P, Cummins C, et al. Incidents of henoch schoenlein purpura, Kawasaki disease, and rare vascular disease in children of different ethnic origin. Lancet. 2002;360(9341):1197–1202.
   PubMed Web of Science ®Google Scholar
• He X, Yu C, Khao P, et al. The genetics of Henoch-Schonlen purpura: a systemic review and meta-analysis. Rheumatol Int. 2013;33(6):1387–1395.
   PubMed Web of Science ®Google Scholar
• Cavvo-Rio V, Loricera J, Ortiz-Sanjuan F, et al. Revisiting clinical differences between hypersensitivity vasculitis and he knocked schoenlein purpura in adults from a defined population. Clin Exp Rheumatol. 2014;32:S34–40.
   PubMed Web of Science ®Google Scholar
• Terrier B, Cacoub P. Cryoglobulinemia vasculitis: an update. Curr Opin Rheumatol. 2013;25(1):10–18.
   PubMed Web of Science ®Google Scholar
• Kluger N, Frances C. Cutaneous vasculitis and their differential diagnoses. Clin Exp Rheumatol. 2009;27(1 Suppl 52):S124–38.
   PubMed Web of Science ®Google Scholar
• Frumholtz L, Laurent-Roussel S, Lipsker D, et al. Cutaneous Vasculitis: review on Diagnosis and Clinicopathologic Correlations. Clin Rev Allergy Immunol. 2021;61(2):181–193.
   PubMed Web of Science ®Google Scholar
• Reamy BV, Servey JT, Williams PM. Henoch-Schönlein Purpura (IgA Vasculitis): rapid Evidence Review. Am Fam Physician. 2020 Aug;102(4):229–233.
   PubMed Web of Science ®Google Scholar
• Ko CJ, Gehlhausen JR, McNiff JM. Leukocytoclastic vasculitis and microvascular occlusion: key concepts for the working pathologist. Surg Pathol Clin. 2021;14(2):309–325.
   PubMedGoogle Scholar
• Carlson JA. The histological assessment of cutaneous vasculitis. Histopathology. 2010;56(1):3–23.
   PubMed Web of Science ®Google Scholar
• Bahrami S, Malone JC, Webb KG, et al. Tissue eosinophilia as an indicator of drug induced cutaneous small vessel vasculitis. Arch Dermatol. 2006;142(2):155–161.
   PubMedGoogle Scholar
• Morita TCAB, Trés GFS, Critado RFJ, et al. Update on vasculitis: an overview and dermatological clues for clinical and histopathological diagnosis—Part I. An Bras Dermatol. 2020;95(3):355–371.
   PubMed Web of Science ®Google Scholar
• Crowson AN, Mihm Jr JMC, Magro CM. Cutaneous vasculitis: a review. J Cutan Pathol. 2003 Mar;30(3):161–173.
   PubMed Web of Science ®Google Scholar
• Garcia-Porrua C, Gonzalez-Gay MA, Lopez-Lazaro L. Drug associated cutaneous vasculitis in adults in northwestern Spain. J Rheumatol. 1999;26(9):1942–1944.
   PubMed Web of Science ®Google Scholar
• Grau RG. Drug induced vasculitis: new insights and a changing lineup of suspects. Curr Rheumatol Rep . 2015;17(12):71.
   PubMed Web of Science ®Google Scholar
• Sokumbi O, Wetter DA, Makol A. Vasculitis associated with tumor necrosis factor alpha inhibitors. Mayo Clin Proc. 2012;87(8):739–745.
   PubMed Web of Science ®Google Scholar
• Kandula P, Kouides PA. Rituximab induced leukocytoclastic vasculitis: a case report. Arch Dermatol. 2006;142(2):246–247.
   PubMedGoogle Scholar
• Sakaue S, Sumitomo S, Kubo K, et al. Tocilizumab induced leukocytoclastic vasculitis in a patient with rheumatoid arthritis. Rheumatology. 2014;53(8):1529–1530.
   PubMed Web of Science ®Google Scholar
• Gonen KA, Erfan G, Oznur M, et al. The first case of Henoch-Schoenlein purpura associated with rosuvastatin: colonic involvement coexisting with small intestine. BMJ Case Rep. 2014;2014(mar19 1):bcr2013202644–bcr2013202644.
   PubMedGoogle Scholar
• Tomelleri A, Campochiaro C, De Luca G. Anti-PD1 therapy associated cutaneous leukocytoclastic vasculitis: a case series. Eur J Intern Med. 2018;1(57):11–12.
   Google Scholar
• Chérrez-Ojeda I, Loayza E, Greiding L, et al. Urticarial vasculitis induced by OTC diet pills: a case report. World Allergy Organ J. 2015;8(1):12.
   PubMedGoogle Scholar
• Fiorillo G, Pancetti S, Cortese A, et al. Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination. J Autoimmun. 2022;127:102783.
   PubMed Web of Science ®Google Scholar
• Cohen SR, Prussick L, Kahn JS, et al. Leukocytoclastic vasculitis flare following the COVID-19 vaccine. Int J Dermatol. 2021;60(8):1032–1033.
   PubMed Web of Science ®Google Scholar
• Bostan E, Gulseren D, Gokoz O. New-onset leukocytoclastic vasculitis after COVID-19 vaccine. Int J Dermatol. 2021;60(10):1305–1306.
   PubMed Web of Science ®Google Scholar
• Bencharattanaphakhi R, Rerknimitr, Rerknimitr P. Sinovac COVID-19 vaccine-induced cutaneous leukocytoclastic vasculitis. JAAD Case Rep. 2021 Dec;18:1–3.
   PubMedGoogle Scholar
• Sandhu S, Bhatnagar A, Kumar H, et al. Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV-19 Corona virus vaccine (recombinant). Dermatol Ther. 2021;34(6):e15141.
   Web of Science ®Google Scholar
• Grossman ME, Appel G, Little AJ, et al. Post COVID-19 vaccination IGA vasculitis in an adult. J Cutan Pathol. 2022;49(4):385–387.
   PubMed Web of Science ®Google Scholar
• Bonetto C, Trotta F, Felicetti P, et al. Vasculitis as an adverse event following immunization- Systemic literature review. Vaccine. 2016;34(51):6641–6651.
   PubMed Web of Science ®Google Scholar
• Carlson JA, Ng BT, Chen KR. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopath. 2005;27(6):504–528.
   PubMed Web of Science ®Google Scholar
• Belizna CC, Hamidou MA, Levesque H, et al. Infection and vasculitis. Rheumatology. 2009;48(5):475–482.
   PubMed Web of Science ®Google Scholar
• Wong K, Shah MUFA, Khurshid M, et al. COVID-19 associated vasculitis: a systemic Review of case reports and case series. Ann Med Surg. 2002;74:1–5.
   Google Scholar
• Blanco R, Martínez-Taboada VM, Rodríguez-Valverde V, et al. Cutaneous vasculitis in children and adults: associated diseases and etiologic factors in 303 patients. Medicine (Baltimore). 1998;77(6):403–418.
   PubMed Web of Science ®Google Scholar
• Barile-Fabris L, Hernandez-Cabrera MF, Barragan-Garfias JA. Vaculitis in systemic lupus erythematosus. Curr Rheumatol Rep. 2014;16(9):440.
   PubMed Web of Science ®Google Scholar
• Schroeter AL, Conn DL, Jordon RE. Immunoglobulin and complement deposition in skin of rheumatoid arthritis and systemic lupus erythema ptosis patients. Ann Rheum Dis. 1976;35(4):321–326.
   PubMed Web of Science ®Google Scholar
• Blanco R. Cutaneous vasculitis: an unusual presentation of sarcoidosis in adulthood. Scand J Rheumatol. 1998;27(1):80–82.
   PubMed Web of Science ®Google Scholar
• Loricera J, Calvo-Rio V, Ortiz-Sanjuan F, et al. The spectrum of paraneoplastic cutaneous vasculitis in a defined population: incidence and clinical features space Med. Medicine. 2013;92(6):331–343.
   PubMed Web of Science ®Google Scholar
• Bouiller K, Audia S, Devilliers H, et al. Etiologies and prognostic factors of leukocytoclastic vasculitis with skin involvement: a retrospective study in 112 patients. Med (United States). 2016;95(28):e4238.
   Google Scholar
• Sais G, Vidaller A, Jucqla A. Colchicine in the treatment of cutaneous leukocytoclastic vasculitis. Results of a prospective, randomized controlled trial. Arch Dermatol. 1995;131(12):1399.
   PubMedGoogle Scholar
• Fredenberg MF, Malkinson FD. Sulfone therapy in the treatment of leukocytoclastic vasculitis. Report of three cases. J Am Acad Dermatol. 1987;16(4):772–778.
   PubMed Web of Science ®Google Scholar
• Lopez L, Davis KC, Kohler PF, et al. The hypocomplementemic urticarial-vasculitis syndrome: therapeutic response to hydroxychloroquine. J Allergy Clin Immunol. 1984;73(5):600–603.
   PubMed Web of Science ®Google Scholar
• Jorrizo JL, White WL, Wise CM. Low dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Behcet’s disease. Journal of the American Academy of Dermatology. 1991;24(6):973–978.
   PubMed Web of Science ®Google Scholar
• Haeberle MT, Adams WB, Callen JP. Treatment of severe cutaneous small vessel vasculitis with mycophenolate mofetil. Arch Dermatol. 2012;148(8):887–888.
   PubMedGoogle Scholar
• Callen JP, Spencer LV, Burruss JB, et al. Azathioprine: an effective, corticosteroid sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis. Arch Dermatol. 1991;127(4):515–522.
   PubMedGoogle Scholar
• Goeser MR, Laniosz V, Wetter DA. A practical approach to the diagnosis, evaluation, and management of cutaneous small-vessel vasculitis. Am J Clin Dermatol. 2014;15(4):299–306.
   PubMed Web of Science ®Google Scholar
• De Vita S, Quartuccio L, Isola M. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum. 2012;64(3):843–853.
   PubMed Web of Science ®Google Scholar
• Maritati F, Fenoglio R, Pillebout E, et al. Brief report: rituximab for the treatment of adult onset IGA vasculitis parentheses henoc schoenlein in parentheses arthritis and rheumatism. Arthritis & Rheumatology (Hoboken, N.J.). 2018;70(1):109–114.
   PubMedGoogle Scholar
• Chérrez-Ojeda I, Vanegas E, Felix M, et al. Patient-reported outcomes in urticarial vasculitis treated with omalizumab: case report. BMC Dermatol. 2018;18(1):8.
   PubMedGoogle Scholar
• Pastuszczak M, Celinska-Lowenhoff M, Sulowicz J, et al. Clinical study on single organ cutaneous vessels vasculitis (SoCSVV) Medicine. Medicine. 2017;96(12):e6376.
   PubMed Web of Science ®Google Scholar
• Fiorentino DF. Cutaneous vasculitis. J Am Acad Dermatol. 2003 Mar;48(3):311–340.
   PubMed Web of Science ®Google Scholar
• Saulsbury FT. Clinical update: henoch-Schonlein purpura. Lancet. 2007;369(9566):976–978.
   PubMed Web of Science ®Google Scholar
• Jauhola O, Ronkainen J, Koskimies O, et al. Renal manifestations of Henoch Schonlein purpura in a 6-month prospective study of 223 children. Arch Dis Child. 2010;95(11):877–882.
   PubMed Web of Science ®Google Scholar